Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.570
+0.010 (0.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Apyx Medical.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Apyx Medical stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 1 | 1 | 1 | 0 |
Hold | 1 | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 2 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +218.47% | Nov 10, 2023 |
Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +186.62% | Aug 11, 2023 |
Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +409.55% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
47.85M
from 52.35M
Decreased by -8.60%
Revenue Next Year
49.18M
from 47.85M
Increased by 2.78%
EPS This Year
-0.72
from -0.54
EPS Next Year
-0.41
from -0.72
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 49.6M | 51.5M | 55.3M | |||
Avg | 47.8M | 49.2M | 53.1M | |||
Low | 45.6M | 46.6M | 50.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -5.2% | 7.7% | 12.4% | |||
Avg | -8.6% | 2.8% | 7.9% | |||
Low | -12.8% | -2.6% | 2.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.71 | -0.35 | -0.32 |
Avg | -0.72 | -0.41 | -0.38 |
Low | -0.71 | -0.44 | -0.43 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.